Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,157
Total Claims
$724K
Drug Cost
934
Beneficiaries
$775
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+25%
Opioid rate vs peers
3.2% vs 2.6% avg
-27%
Cost per patient vs peers
$775 vs $1,068 avg
-19%
Brand preference vs peers
7.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.2%
Opioid Rate
360
Opioid Claims
$6,248
Opioid Cost
4.2%
Long-Acting Rate
Brand vs Generic
Brand: 806 claims · $497K
Generic: 10,295 claims · $225K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 49 | $80K |
| Dapagliflozin Propanediol | 69 | $69K |
| Dulaglutide | 37 | $68K |
| Apixaban | 57 | $59K |
| Semaglutide | 38 | $48K |
| Liraglutide | 11 | $33K |
| Umeclidinium Brm/Vilanterol Tr | 21 | $18K |
| Icosapent Ethyl | 33 | $16K |
| Fluticasone/Umeclidin/Vilanter | 15 | $15K |
| Atorvastatin Calcium | 844 | $12K |
| Mirabegron | 14 | $11K |
| Rosuvastatin Calcium | 655 | $11K |
| Icosapent Ethyl | 22 | $8,958 |
| Fluticasone/Vilanterol | 20 | $8,487 |
| Losartan Potassium | 488 | $6,603 |
Prescribing Profile
Patient Profile
75
Avg Age
39%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About